PlainPill

THC

Also known as Cannabis, Marijuana

The short answer. Most people who report on THC say it did not help (only 26% of 295 positive). It is most often used for anxiety: 33% of 96 reports say that improved. It is well studied — 249 meta-analyses on PubMed. The most common complaint is anxiety.

What users report
26%helped295 reports · high confidence
78 helped117 mixed100 didn't help

From 434 mentions in total — the rest didn't say how it went and aren't counted.

Clinical research
AStrong research base
249
meta-analyses
488
RCTs
12,030
papers

What THC does, according to users

Of the people who reported each effect, the share who said it got better.

What the research says

Systematic reviews and meta-analyses from PubMed, with their published conclusions.

AStrong research base

3+ meta-analyses or systematic reviews and 10+ randomized controlled trials in humans. The grade measures how much human research exists — read the conclusions below for what it found. 249 meta-analyses on PubMed ↗ · 488 randomized trials ↗

Eur Arch Psychiatry Clin Neurosci · 2020 · Meta-analysis / systematic review
Cannabis use and psychosis: a review of reviews

Conclusion: Cannabis use was also associated with increased relapse rates, more hospitalizations and pronounced positive symptoms in psychotic patients. We make recommendations about the type of research that is required to better characterize the relationship between cannabis use and the development and outcomes of psychosis.

PubMed 31563981 ↗
Lancet Psychiatry · 2019 · Meta-analysis / systematic review
Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis

Conclusion: There is scarce evidence to suggest that cannabinoids improve depressive disorders and symptoms, anxiety disorders, attention-deficit hyperactivity disorder, Tourette syndrome, post-traumatic stress disorder, or psychosis. There is very low quality evidence that pharmaceutical THC (with or without CBD) leads to a small improvement in symptoms of anxiety among individuals with other medical conditions. There remains insufficient evidence to provide guidance on the use of cannabinoids for treating mental disorders within a regulatory framework. Further high-quality studies directly examining the

PubMed 31672337 ↗
Cochrane Database Syst Rev · 2023 · Meta-analysis / systematic review
Cannabis-based medicines and medical cannabis for adults with cancer pain

Conclusion: There is moderate-certainty evidence that oromucosal nabiximols and THC are ineffective in relieving moderate-to-severe opioid-refractory cancer pain. There is low-certainty evidence that nabilone is ineffective in reducing pain associated with (radio-) chemotherapy in people with head and neck cancer and non-small cell lung cancer. There is low-certainty evidence that a single dose of synthetic THC analogues is not superior to a single low-dose morphine equivalent in reducing moderate-to-severe cancer pain. There is low-certainty evidence that CBD does not add value to specialist palliative c

PubMed 37283486 ↗
BMC Psychiatry · 2020 · Meta-analysis / systematic review
Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review

Conclusion: There is currently encouraging, albeit embryonic, evidence for medicinal cannabis in the treatment of a range of psychiatric disorders. Supportive findings are emerging for some key isolates, however, clinicians need to be mindful of a range of prescriptive and occupational safety considerations, especially if initiating higher dose THC formulas.

PubMed 31948424 ↗

What government agencies say

Official records from US, Canadian and EU regulators, each linked to its source.

US legal status (DEA)

THC is a Schedule I controlled substance in the US (listed as Tetrahydrocannabinols). DEA controlled-substance list ↗

US government research funding (NIH)

NIH has funded 116 research projects with THC in the title, $106,840,678 in total (1985–2026). NIH RePORTER ↗

Dosage people report

As stated by users — not a recommendation. Follow the label or your doctor.

7 mgonce a week
3 gas reported
10 mgas reported
25 mgas needed
2-5 gweekly

Reported side effects

How often each side effect came up across all reports.

anxiety ×23brain fog ×13vivid dreams ×11paranoia ×11insomnia ×5depersonalization ×4derealization ×4memory impairment ×4

What users say

First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.

“once a week I smoke a little weed before the gym (sativa Pre-roll sour diesel from medmen) and it actually made me feel normal.”
HelpedRead the discussion ↗
“I tried using THC just before bed and it seemed to be magic... It also greatly improved my migraines from 3-4 times a week to 3-4 times a MONTH!”
MixedRead the discussion ↗
“Weed If you need to calm yourself before bed but I find sometimes I wake up a few hours later with weed.”
MixedRead the discussion ↗
“Strangely I also find weed helps me sleep better too. And doesnt affect my rem like I thought it would. But I only smoke once a week.”
HelpedRead the discussion ↗
Read more THC reviews →
Top discussions (5)

THC compared

Other options for anxiety

Sources

User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 5, 2026. How we rate